Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Infusions, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 3 Myelodysplastic Syndromes 2 Metastatic Solid Tumors 2 Melanoma 2 Glioma 2 Solid Tumors 1 Rhabdoid Tumor 1 Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1 Recurrence 1 Prostate Cancer Patients Undergoing Radical Prostatectomy 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Neoadjuvant Treatment for Locally Advanced Cervical Cancer 1 Myeloproliferative Disorders 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Neoplasms 1 Breakthrough Pain 1 Brain Neoplasms 1 Advanced Malignant Neoplasm 1

Interventions

Fluorouracil 433 Bevacizumab 408 Oxaliplatin 385 Leucovorin 381 Irinotecan 355 Cetuximab 275 Capecitabine 275 pembrolizumab 125 Folfox protocol 113 Panitumumab 97 regorafenib 93 Colonoscopy 73 IFL protocol 72 Drug Therapy 67 Nivolumab 66 trifluridine tipiracil drug combination 61 Radiotherapy 59 HMPL-013 52 Blood Specimen Collection 49 Gemcitabine 43 Neoadjuvant Therapy 42 Specimen Handling 40 Chemotherapy, Adjuvant 38 Biopsy 38 Standard of Care 37 Cyclophosphamide 37 Surveys and Questionnaires 34 Magnetic Resonance Spectroscopy 34 atezolizumab 33 Trifluridine 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00399035 2016-12-28

HORIZON II

AstraZeneca

Phase 3 Completed

1,254 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡